Comparison of pharmacokinetics of neoral and sandimmune in stable pediatric liver transplant recipients
Indra D. M. van Mourik, Mike Thomson, Deirdre A. Kelly – 30 December 2003 – Cyclosporine (Sandimmune; Novartis Pharmaceuticals UK Ltd) is an effective immunosuppressive drug, but its lipid formulation and variable absorption may expose children to the risk of rejection during episodes of gastroenteritis after liver transplantation. Neoral (Novartis) is a microemulsified form of cyclosporine that may be better absorbed.